Product news

Share this article:

GlaxoSmithKline announced that the European Commission has granted a marketing authorization for its cervical cancer vaccine, Cervarix, for all 27 European member states.  Cervarix is indicated for the prevention of precancerous cervical lesions and cervical cancer causally related to human papillomavirus (HPV) types 16 and 18. The indication is based on data generated in girls and women aged between 10 and 25.


Novo Nordisk announced that its Norditropin (somatropin [rDNA origin] injection) received approval from the FDA for the treatment of children with short stature associated with Turner syndrome.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.

IRS struggles with device tax

A Treasury report says the IRS is having trouble identifying who owes it money.

White House proposes Hobby Lobby alternative

A proposal by the Obama administration Friday seeks to keep contraception accessible and coverage approval at arm's length for employees of religious non-profits.